Skip to main content
SpringerLink
Log in

Will There Ever be an Antidote for Drug Shortages?

  • The Poison Pen
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Mazer-Amirshahi M, Hawley KL, Zocchi M, Fox E, Pines JM, Nelson LS. Drug shortages: implications for medical toxicology. Clin Toxicol (Phila). 2015;53:519–24.

    Article  CAS  Google Scholar 

  2. ASHP Drug Shortages. https://www.ashp.org/Drug-Shortages/Current-Shortages/Drug-Shortage-Detail.aspx?id=659&loginreturnUrl=SSOCheckOnly. Accessed 30 Jan 2021.

  3. World Health Organization. WHO model lists of essential medicines. https://www.who.int/groups/expert-committee-on-selection-and-use-of-essential-medicines/essential-medicines-lists. Accessed 26 Jan 2021.

  4. World Health Organization. Review of succimer for the treatment of lead poisoning. https://www.who.int/selection_medicines/committees/expert/18/applications/succimer.pdf?ua=1. Accessed 30 Jan 2021.

  5. U.S. Food and Drug Administration. Search list of extended use dates to assist with drug shortages. https://www.fda.gov/drugs/drug-shortages/search-list-extended-use-dates-assist-drug-shortages. Accessed 26 Jan 2021.

  6. FDA Agency Drug Shortage Task Force. https://www.fda.gov/drugs/drug-shortages/agency-drug-shortages-task-force. Accessed 30 Jan 2021.

  7. United States Senate. S 3548 Coronavirus Aid, Relief, and Economic Security (CARES) Act. https://www.congress.gov/116/bills/s3548/BILLS-116s3548is.pdf. Accessed 26 Jan 2021.

  8. The National Academies of Sciences Engineering and Medicine. Securities of America’s Medical Product Supply Chain. https://www.nationalacademies.org/our-work/security-of-americas-medical-product-supply-chain. Accessed 30 Jan 2021.

Download references

Funding

The authors have no financial relationships relevant to this article to disclose.

Author information

Authors and Affiliations

  1. Department of Pharmacy Services, University of Utah Health, Salt Lake City, UT, USA

    Erin R. Fox

  2. National Capital Poison Center, Washington, DC, USA

    Kelly Johnson-Arbor

  3. MedStar Georgetown University Hospital, Washington, DC, USA

    Kelly Johnson-Arbor & Maryann Mazer-Amirshahi

  4. Department of Emergency Medicine, MedStar Washington Hospital Center, Washington, DC, USA

    Maryann Mazer-Amirshahi

Authors
  1. Erin R. Fox
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kelly Johnson-Arbor
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maryann Mazer-Amirshahi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Maryann Mazer-Amirshahi.

Ethics declarations

Conflict of interest

None.

Additional information

Supervising Editor: Lewis S. Nelson, MD

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fox, E.R., Johnson-Arbor, K. & Mazer-Amirshahi, M. Will There Ever be an Antidote for Drug Shortages?. J. Med. Toxicol. 17, 321–322 (2021). https://doi.org/10.1007/s13181-021-00830-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13181-021-00830-x

Keywords

Search

Navigation